CLOSE X

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1337.007.1 (+0.53 %)
PREV CLOSE ( ) 1329.90
OPEN PRICE ( ) 1336.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 43795
TODAY'S LOW / HIGH ( )1313.55 1337.00
52 WK LOW / HIGH ( )1165.55 1672.2
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Achin Gupta - Managing Director
Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 41916000

Email contactus@cipla.com / cosecretary@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
NEWS
23Oct Cipla informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
23Oct USFDA completes cGMP inspection at Cip
The United States Food and Drug Administration (USFDA) has conducted an..
04Sep Cipla’s arm partners with Qilu for lic
Cipla’s wholly owned subsidiary -- Invagen Pharmaceuticals Inc has enter..
04Sep Cipla inches up as its arm partners wi
Cipla is currently trading at Rs. 1390.90, up by 1.90 points or 0.14% fr..
31Aug Cipla signs licensing agreement with S
Cipla and Sino Biopharmaceutical’s (SBP Group) subsidiary, Chia Tai Tian..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit8621.635151.8
Gross Profit 11536.2 46359.4
Operating Profit 13286.955890.4
Net Sales 50776.8189799.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ipca Laboratories (BSE)
 1964.70 (3.26%)
M.Cap ( in Cr)49845.27
Ajanta Pharma (BSE)
 3300.00 (0.90%)
M.Cap ( in Cr)41236.48
Trident Lifeline (BSE)
 410.00 (3.99%)
M.Cap ( in Cr)491.22
Senores Pharmaceutic (BSE)
 1213.90 (0.95%)
M.Cap ( in Cr)5590.45
Anthem Biosciences (BSE)
 812.15 (1.29%)
M.Cap ( in Cr)45766.93
Shareholding Pattern
PROMOTERS 29.21%
MUTUAL FUNDS/UTI 20.78%
NON-INSTITUTION 15.61%
FI/BANKS/INSURANCE 11.83%
GOVERNMENT 0%
FII 0%
Advisory for Investors Complaints Data September 2026 Broking Complaints Data September 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES| SEBI PRESENTS SAMAJH SE INVESTING SIMPLE

© Badjate Group 2018

Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.